Skip to main navigation Skip to search Skip to main content

An evaluation of Bone Mineral Denisty in HIB-1-infected adult subjects switching from a tenofovir-containing antiretoviral therapy regimen to a dolutegravir plus pilpivirin regimen - 202094

Project: Research

Project Details

StatusFinished
Effective start/end date07/27/15 → 03/31/17

Funding

  • GlaxoSmithKline: $3,250.00